Skip to main content
Bishoy Faltas, MD, Oncology, New York, NY

BishoySobhy MorrisFaltasMD

Oncology New York, NY

Genitourinary Oncology, Hematologic Oncology

Director, Bladder Cancer Research, Englander Institute for Precision Medicine, Gellert Family-John P. Leonard, MD Research Scholar, Assistant Professor of Medicine, Assistant Professor of Cell and Developmental Biology, Weill Cornell Medicine

Overview of Dr. Faltas

Dr. Bishoy Faltas is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian Hospital, and New York-Presbyterian Hospital. He received his medical degree from University of Assiut Faculty of Medicine and has been in practice 12 years. He is one of 379 doctors at New York-Presbyterian Hospital and one of 379 doctors at New York-Presbyterian Hospital who specialize in Oncology. He has more than 100 publications and over 500 citings.

Education & Training

  • New York-Presbyterian Hospital
    New York-Presbyterian HospitalPost-Doctoral Fellowship, 2015 - 2016
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 2012 - 2015
  • Rochester General Hospital
    Rochester General HospitalResidency, Internal Medicine, 2006 - 2009
  • University of Assiut Faculty of Medicine
    University of Assiut Faculty of MedicineClass of 2005

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2009 - 2026
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • ASCI-YPSA Young Physician-Scientist Awards The American Society for Clinical Investigation, 2022
  • NextGen Star American Association for Cancer Research (AACR), 2017
  • Finalist, 2nd place for best research presentation Immuno-oncology Young Investigators’ forum, 2016
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.  
    Beltran H, Eng K, Mosquera JM, Sigaras A, Romanel A, Rennert H, Kossai M, Pauli C, Faltas B, Fontugne J, Park K, Banfelder J, Prandi D, Madhukar N, Zhang T, Padilla J,..., JAMA Oncol
  • Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation  
    Douketis JD, Spyropoulos AC, Kaatz S, Becker RC, Caprini JA, Dunn AS, Garcia DA, Jacobson A, Jaffer AK, Kong DF, Schulman S, Turpie AG, Hasselblad V, Ortel TL; BRIDGE ..., N Engl J Med, 1/1/2015
  • A Precision Medicine Trial for Whole Exome Sequencing of Metastatic Cancer Reveals Biomarkers of Treatment Response  
    Beltran H, Eng K, Mosquera JM, Sigaras A, Romanel A, Rennert H, Kossai M, Pauli C, Faltas B, Fontugne J, Park K, Banfelder J, Prandi D, Madhukar N, Zhang T, Padilla J,..., JAMA Oncol, 1/1/2015
  • Join now to see all

Abstracts/Posters

  • Whole exome sequencing reveals 19q13 amplification and actionable mutations in carcinosarcoma of the bladder.
    Peyman Tavassoli, Bishoy Faltas, Joanna Cyrta, Juan Miguel Mosquera, Brian D Robinson, Mark Rubin, United States & Canadian Academy of Pathology (USCAP) Meeting, 1/1/2016
  • Integrated whole exome and RNA sequencing reveals distinct genomic and transcriptomic landscape of upper tract urothelial carcinoma.
    Bishoy Faltas, Rohan Bareja, Himisha Beltran, Joanna Cyrta, Manoj P. Rai, Scott T. Tagawa, David Nanus, Juan Miguel Mosquera, Andrea Sboner, Douglas Scherr, Olivier El..., American Society of Clinical Oncology Genitourinary Symposium (ASCO-GU), 1/1/2016
  • Treatment for metastatic platinum-resistant urothelial cancer (PRUC) with an anti-Trop-2-SN-38 antibody-drug conjugate (ADC), sacituzumab govitecan (IMMU-132): phase I...
    Scott T. Tagawa, Bishoy Faltas, Elaine Lam, Wells A. Messersmith, Philip Saylor, Aditya Bardia, Julio J. Hajdenberg, Alicia K. Morgans, Jordan D. Berlin, Emerson Lim, ..., American Association for Cancer research (AACR) annual meeting, 1/1/2016
  • Join now to see all

Lectures

  • Generating a neoantigen map of advanced urothelial carcinoma by whole exome sequencing. 
    1/1/2016
  • Clonal heterogeneity in platinum-resistant metastatic urothelial cancer. 
    1/1/2015

Other

  • Making new medicines- How next generation sequencing is transforming drug-development. 
    Faltas B, Bitesizebio
    1/18/2013
  • Never a Dull Moment: A Day in the Life of an Oncology Fellow. 
    Faltas B, ASCO Post
    1/15/2013
  • The Nuts and Bolts of Getting into an Oncology Fellowship 
    Faltas B, ASCO Post
    1/15/2012
  • Join now to see all

Press Mentions

  • Oncologist Receives Prestigious MERIT Grant from the National Cancer Institute for Bladder Cancer Research
    Oncologist Receives Prestigious MERIT Grant from the National Cancer Institute for Bladder Cancer ResearchMarch 1st, 2024
  • Cancer Projects to Diversify Genetic Research Receive New Grants
    Cancer Projects to Diversify Genetic Research Receive New GrantsSeptember 11th, 2020
  • Mutations, DNA Structures Linked to Bladder Cancer
    Mutations, DNA Structures Linked to Bladder CancerOctober 12th, 2024
  • Join now to see all

Professional Memberships